Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 323 (RNA5SP323)

Target
RNA5SP323
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, 5S ribosomal pseudogene 323 (RNA5SP323) is classified as a processed pseudogene, specifically one of many related to the 5S ribosomal RNA gene, which is a highly conserved structural RNA component of the large ribosomal subunit[2][5]. As a pseudogene, RNA5SP323 does not encode a functional RNA or protein product due to disabling mutations and lack of necessary regulatory elements for transcription[2]. Processed pseudogenes like RNA5SP323 generally arise via reverse transcription and reintegration of RNA transcripts, often lacking introns and original regulatory elements, and are non-functional remnants dispersed throughout the genome[2]. Pseudogenes are not usually considered therapeutic targets—they do not encode active enzymes, receptors, or other druggable proteins. However, recent research has identified functional roles for some expressed pseudogenes in gene regulation or disease contexts, including cancer, but there is no evidence that RNA5SP323 specifically is functional or disease-associated[8]. RNA5SP323 is not a valid therapeutic target (e.g., not a receptor, enzyme, or transporter)[2][5]. It is a probable genomic annotation artifact, listed as a pseudogene with no current evidence for coding or regulatory function[2][4]. There is no evidence for drug interactions, biomarker utility, or a defined molecular mechanism[2][3][5]. The parental gene, 5S ribosomal RNA, is a critical component of ribosomes involved in protein synthesis and ribosome assembly[3][5]; however, the pseudogene itself does not contribute to these functions. Pseudogene expression (generally, not for this specific pseudogene) is a subject of cancer biology research as potential long non-coding RNAs or regulatory RNAs, but this is not established for RNA5SP323[8]. This entry is not a classical therapeutic target, is a non-functional pseudogene, and does not warrant inclusion in a database of druggable proteins or functional molecular targets. There is no evidence for its direct biological or medical relevance beyond being a genomic relic.

Other names
RN5S323RNA, 5S ribosomal 323RNA5SP323
02

Disease associations

Other

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 323 (RNA5SP323).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 323 (RNA5SP323).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call